Cargando…
Multidrug-resistant Tuberculosis Management in Resource-limited Settings
Evidence of successful management of multidrug-resistant tuberculosis (MDRTB) is mainly generated from referral hospitals in high-income countries. We evaluate the management of MDRTB in 5 resource-limited countries: Estonia, Latvia, Peru, the Philippines, and the Russian Federation. All projects we...
Autores principales: | Nathanson, Eva, Lambregts-van Weezenbeek, Catharina, Rich, Michael L., Gupta, Rajesh, Bayona, Jaime, Blöndal, Kai, Caminero, José A., Cegielski, J. Peter, Danilovits, Manfred, Espinal, Marcos A., Hollo, Vahur, Jaramillo, Ernesto, Leimane, Vaira, Mitnick, Carole D., Mukherjee, Joia S., Nunn, Paul, Pasechnikov, Alexander, Tupasi, Thelma, Wells, Charles, Raviglione, Mario C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3294733/ https://www.ncbi.nlm.nih.gov/pubmed/17073088 http://dx.doi.org/10.3201/eid1209.051618 |
Ejemplares similares
-
Additional Drug Resistance of Multidrug-Resistant Tuberculosis in Patients in 9 Countries
por: Kurbatova, Ekaterina V., et al.
Publicado: (2015) -
Multidrug-Resistant TB in the Philippines: Authors' Reply
por: Tupasi, Thelma
Publicado: (2006) -
Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study
por: Yuen, Courtney M., et al.
Publicado: (2015) -
Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis
por: Skripconoka, Vija, et al.
Publicado: (2013) -
Ascertainment Bias in TB Treatment Trials: Can Systematic Assessment of Objective Endpoints Solve It?
por: Mitnick, Carole D., et al.
Publicado: (2023)